Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary Infection

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary Infection	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, mycobacterial infectious disease, respiratory system disorder	Recruiting	Phase 2	2025-11-19		NCT06585020

28 results · Page 1 of 2

Swipe the table sideways for more columns.

Organizations	Linked trials
Abbeville Hospital Center	3
APHM - Nord	2
Central Hospital Saint Quentin	5
Centre Hospitalier Intercommunal de Compiègne-Noyon	5
Centre Hospitalier le Mans	19
Centre Hospitalier Universitaire Dijon	130
Centre Hospitalier Universitaire, Amiens	198
CH Cannes	1
CH Mulhouse	1
CH Orléans	1
CH Pontoise	2
CHU de Reims	53
CHU de Rouen - Accueil	5
Créteil Hospital	1
Hospital Avicenne	8
Hôpital de la Croix-Rousse	3
Hôpital Necker-Enfants Malades	15
Hôpital Saint Joseph	1
IHU Strasbourg	10
Perpignan Hospital Center	3
Poitiers University Hospital	76
Rennes University Hospital	89
Tenon Hospital, Paris	7
University Hospital, Angers	123
University Hospital, Bordeaux	221

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
CHU Amiens-Picardie	Amiens	France	30

Clinical trials